
[摘要] 目的 對(duì)臨床檢驗(yàn)不合格血液標(biāo)本的分析與對(duì)策進(jìn)行探討,為今后的臨床工作提供可靠的參考依據(jù)。方法 抽取在2012年1月—2014年12月間該院實(shí)驗(yàn)室驗(yàn)收不合格血液標(biāo)本276份,對(duì)其臨床檢驗(yàn)結(jié)果進(jìn)行統(tǒng)計(jì)分析,并總結(jié)不合格標(biāo)本出現(xiàn)的原因與對(duì)策。結(jié)果 該組276份不合格標(biāo)本中來(lái)自5 359份血液標(biāo)本,不合格發(fā)生率為5.15%,276份不合格標(biāo)本中包含有樣本量少75份,抗凝不全標(biāo)本56份,溶血標(biāo)本32份,凝血標(biāo)本27份,送檢不及時(shí)導(dǎo)致樣品不合格26份,容器不當(dāng)標(biāo)本13份受檢者準(zhǔn)備不足導(dǎo)致標(biāo)本不合格16例,標(biāo)簽不合理樣品16份,標(biāo)本污染15份。結(jié)論 導(dǎo)致臨床檢驗(yàn)血液標(biāo)本不合格的原因較多,相關(guān)醫(yī)務(wù)工作者應(yīng)做好預(yù)防對(duì)策,減少不合格標(biāo)本的出現(xiàn)率,提高臨床檢驗(yàn)工作質(zhì)量,為臨床診治工作提供更加可靠的參考依據(jù)。
[關(guān)鍵詞] 臨床檢驗(yàn);不合格血液標(biāo)本;原因;對(duì)策;臨床分析
[中圖分類號(hào)] R446.11 [文獻(xiàn)標(biāo)識(shí)碼] A [文章編號(hào)] 1674-0742(2015)05(c)-0181-02
[Abstract] Objective Analysis of the clinical examination unqualified blood specimen and countermeasures were discussed, provide a reliable reference basis for future clinical work. Methods In January 2012 - December 2014 unqualified acceptance of the college laboratory blood samples of 276, the statistical analysis of the clinical testing results and summarize the causes and therapeutic countermeasures of unqualified specimen appeared. Results Unqualified of 276 samples from 5359 blood samples, the unqualified rate is 5.15%, unqualified 276 specimens contained less sample size 75, 56 samples of anticoagulation, hemolysis 32 samples, clotting 27 samples, were not in time lead to 26 samples is unqualified, improper container 13 samples client ill-prepared cause unqualified specimens of 16 cases, unreasonable label sample 16, 15 specimens of pollution. Conclusion The cause of clinical test blood samples is unqualified, relevant countermeasures medical workers should take preventive measures, reduce the occurrence of unqualified specimen rate, improve the quality of clinical inspection work, provide a more reliable reference basis for clinical diagnosis and treatment work.
[Key words] Clinical Laboratory;Unqualified blood samples; Causes ;Countermeasures;Clinical analysis
近幾年的調(diào)查結(jié)果顯示[1],由于現(xiàn)代醫(yī)療水平的不斷提高,使得臨床檢驗(yàn)工作已經(jīng)成為臨床診斷和治療中不可或缺的一種輔助手段。血液標(biāo)本采集并展開(kāi)相關(guān)指標(biāo)檢驗(yàn)可為臨床早期診斷和治療方案選擇提供可靠的參考依據(jù),受到了廣大醫(yī)學(xué)工作者和患者的重視。然而血液標(biāo)本的質(zhì)量將會(huì)對(duì)檢驗(yàn)結(jié)果產(chǎn)生直接的影響,若是存在不合格血液標(biāo)本將影響患者疾病的診斷、病情的評(píng)估,從而延誤治療。因此提高并保證血液標(biāo)本的合格率對(duì)于提高臨床檢驗(yàn)工作質(zhì)量具有重要意義[2]。……